Sam-A Pharm. Co. Ltd - Asset Resilience Ratio

Latest as of December 2025: 36.86%

Sam-A Pharm. Co. Ltd (009300) has an Asset Resilience Ratio of 36.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Sam-A Pharm. Co. Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩91.06 Billion

≈ $61.71 Million USD Cash + Short-term Investments

Total Assets

₩247.04 Billion

≈ $167.42 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2025)

This chart shows how Sam-A Pharm. Co. Ltd's Asset Resilience Ratio has changed over time. See 009300 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Sam-A Pharm. Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 009300 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩91.06 Billion	36.86%
Total Liquid Assets	₩91.06 Billion	36.86%

Asset Resilience Insights

Very High Liquidity: Sam-A Pharm. Co. Ltd maintains exceptional liquid asset reserves at 36.86% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Sam-A Pharm. Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Sam-A Pharm. Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Komipharm International Co. Ltd KQ:041960	Pharmaceuticals	2.23%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%

Annual Asset Resilience Ratio for Sam-A Pharm. Co. Ltd (2009–2025)

The table below shows the annual Asset Resilience Ratio data for Sam-A Pharm. Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	36.86%	₩91.06 Billion ≈ $61.71 Million	₩247.04 Billion ≈ $167.42 Million	+9.12pp
2024-12-31	27.74%	₩68.99 Billion ≈ $46.76 Million	₩248.73 Billion ≈ $168.56 Million	-6.46pp
2023-12-31	34.20%	₩79.10 Billion ≈ $53.61 Million	₩231.31 Billion ≈ $156.75 Million	-3.88pp
2022-12-31	38.07%	₩77.37 Billion ≈ $52.43 Million	₩203.20 Billion ≈ $137.70 Million	+10.07pp
2021-12-31	28.01%	₩52.98 Billion ≈ $35.90 Million	₩189.17 Billion ≈ $128.20 Million	-7.09pp
2020-12-31	35.09%	₩63.91 Billion ≈ $43.31 Million	₩182.11 Billion ≈ $123.41 Million	+18.46pp
2019-12-31	16.63%	₩31.73 Billion ≈ $21.50 Million	₩190.78 Billion ≈ $129.29 Million	-8.69pp
2018-12-31	25.32%	₩43.99 Billion ≈ $29.81 Million	₩173.69 Billion ≈ $117.70 Million	-1.71pp
2017-12-31	27.04%	₩45.41 Billion ≈ $30.77 Million	₩167.97 Billion ≈ $113.83 Million	+3.73pp
2016-12-31	23.30%	₩37.81 Billion ≈ $25.63 Million	₩162.27 Billion ≈ $109.97 Million	+9.45pp
2015-12-31	13.85%	₩21.18 Billion ≈ $14.35 Million	₩152.91 Billion ≈ $103.62 Million	-8.19pp
2014-12-31	22.04%	₩32.15 Billion ≈ $21.79 Million	₩145.86 Billion ≈ $98.85 Million	-3.93pp
2012-12-31	25.97%	₩37.61 Billion ≈ $25.49 Million	₩144.79 Billion ≈ $98.12 Million	+10.01pp
2011-12-31	15.96%	₩22.00 Billion ≈ $14.91 Million	₩137.86 Billion ≈ $93.43 Million	+10.68pp
2010-12-31	5.28%	₩6.79 Billion ≈ $4.60 Million	₩128.75 Billion ≈ $87.25 Million	+1.83pp
2009-12-31	3.45%	₩3.83 Billion ≈ $2.60 Million	₩111.10 Billion ≈ $75.29 Million	--

pp = percentage points

About Sam-A Pharm. Co. Ltd

KQ:009300 Korea Pharmaceuticals

Market Cap

$68.66 Million

₩101.32 Billion KRW

Market Cap Rank

#20645 Global

#1237 in Korea

Share Price

₩16600.00

Change (1 day)

+1.41%

52-Week Range

₩15070.00 - ₩19050.00

All Time High

₩36150.00